Harvard Ave Acquisition Corporation - Rights that convert on a 1/10th of 1 basis to Class A ordinary Shares (HAVAR)

On our desk, HAVAR's steady price action around $0.15 tells a clear story of waiting. With $145 million safely tucked away in the trust account as of the mid-2026 filings, the structure is sound, but the market is heavily discounting the absence of a live target. Until management announces a definitive business combination, retail and institutional interest will likely remain muted given the intense competition in the current SPAC landscape.

When analyzing a vehicle like HAVAR from a quantitative standpoint, zero daily volume is a massive red flag for execution. You cannot build or unwind a meaningful position without slippage. Our technical protocol requires ignoring static nominal prices like $0.15 when order books are completely hollow; fundamental participation requires waiting for an 8-K announcing a target transaction before allocating capital.

Reviewing the 10-Q filings for Harvard Ave Acquisition Corp, the core risk remains structural and temporal. Operating out of Seoul and the Cayman Islands, the blank-check vehicle has capital backing, but the ticking clock without a target creates persistent valuation drag. Investors holding rights that convert on a 1/10th of 1 basis must weigh the dilution mechanics against the ultimate probability of a successful merger before the deadline hits.